Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 100 filers reported holding Y-MABS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $587,915 | -33.7% | 107,874 | -17.4% | 0.00% | – |
Q2 2023 | $886,923 | -29.3% | 130,622 | -47.8% | 0.00% | – |
Q1 2023 | $1,254,750 | -12.5% | 250,449 | -14.8% | 0.00% | – |
Q4 2022 | $1,434,540 | -61.1% | 293,963 | +15.1% | 0.00% | -100.0% |
Q3 2022 | $3,684,000 | -34.9% | 255,492 | -31.7% | 0.00% | 0.0% |
Q2 2022 | $5,660,000 | -12.0% | 374,156 | -30.9% | 0.00% | 0.0% |
Q1 2022 | $6,434,000 | +36.7% | 541,561 | +86.5% | 0.00% | 0.0% |
Q4 2021 | $4,706,000 | +96.3% | 290,384 | +245.7% | 0.00% | – |
Q3 2021 | $2,397,000 | -23.0% | 84,006 | -8.9% | 0.00% | – |
Q2 2021 | $3,114,000 | -52.0% | 92,166 | -57.0% | 0.00% | -100.0% |
Q1 2021 | $6,484,000 | -1.0% | 214,436 | +62.1% | 0.00% | 0.0% |
Q4 2020 | $6,550,000 | +126.3% | 132,285 | +75.5% | 0.00% | 0.0% |
Q3 2020 | $2,894,000 | -18.3% | 75,392 | -8.0% | 0.00% | 0.0% |
Q2 2020 | $3,541,000 | +2484.7% | 81,951 | +1460.7% | 0.00% | – |
Q1 2020 | $137,000 | -98.2% | 5,251 | -97.9% | 0.00% | -100.0% |
Q4 2019 | $7,722,000 | +126.2% | 247,101 | +88.6% | 0.00% | +100.0% |
Q3 2019 | $3,414,000 | +56800.0% | 130,996 | +47020.9% | 0.00% | – |
Q2 2019 | $6,000 | -83.8% | 278 | -79.9% | 0.00% | – |
Q1 2019 | $37,000 | -83.4% | 1,382 | -87.4% | 0.00% | – |
Q4 2018 | $223,000 | +7333.3% | 10,966 | +10866.0% | 0.00% | – |
Q3 2018 | $3,000 | – | 100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 216,916 | $6,191,000 | 3.86% |
Sofinnova Investments, Inc. | 2,194,278 | $62,625,000 | 3.71% |
MPM BioImpact LLC | 452,970 | $12,928,000 | 2.00% |
Soleus Capital Management, L.P. | 265,700 | $7,583,000 | 1.18% |
ASHFORD CAPITAL MANAGEMENT INC | 452,110 | $12,903,000 | 1.17% |
ORACLE INVESTMENT MANAGEMENT INC | 315,642 | $9,008,000 | 1.12% |
First Light Asset Management, LLC | 577,663 | $16,487,000 | 1.09% |
Lombard Odier Asset Management (Switzerland) SA | 352,839 | $10,070,000 | 0.62% |
Cormorant Asset Management, LP | 500,000 | $14,270,000 | 0.58% |
Artal Group S.A. | 400,000 | $11,416,000 | 0.26% |